Compare EQ & ULBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EQ | ULBI |
|---|---|---|
| Founded | 2017 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.4M | 104.3M |
| IPO Year | 2018 | 1995 |
| Metric | EQ | ULBI |
|---|---|---|
| Price | $1.28 | $15.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $8.56 | N/A |
| AVG Volume (30 Days) | ★ 312.5K | 217.7K |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.27 |
| Revenue | $41,095,000.00 | ★ $191,159,000.00 |
| Revenue This Year | N/A | $17.65 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $58.41 |
| Revenue Growth | N/A | ★ 16.24 |
| 52 Week Low | $1.16 | $4.90 |
| 52 Week High | $6.20 | $15.83 |
| Indicator | EQ | ULBI |
|---|---|---|
| Relative Strength Index (RSI) | 40.62 | 91.63 |
| Support Level | $1.24 | $5.76 |
| Resistance Level | $1.51 | N/A |
| Average True Range (ATR) | 0.12 | 0.08 |
| MACD | 0.01 | 0.11 |
| Stochastic Oscillator | 15.79 | 98.88 |
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company also designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.